{"disease":{"id":"colorectal-carcinomatosis","name":"colorectal carcinomatosis"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT02758951","title":"Perioperative Systemic Therapy for Isolated Resectable Colorectal Peritoneal Metastases","phase":"PHASE2, PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":358,"lead_sponsor_name":"Koen Rovers","has_results":false},{"nct_id":"NCT04231175","title":"Dedicated MR Imaging vs Surgical Staging of Peritoneal Carcinomatosis in Colorectal Cancer","phase":"NA","overall_status":"UNKNOWN","enrollment_count":272,"lead_sponsor_name":"The Netherlands Cancer Institute","has_results":false},{"nct_id":"NCT04475159","title":"Combined Neoadjuvant Systemic and PIPAC Therapy (NASPIT) for Patients With Colorectal Peritoneal Metastasis Eligible for CRS and HIPEC: A Prospective Phase II Trial","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":50,"lead_sponsor_name":"Prof. Aviram Nissan","has_results":false},{"nct_id":"NCT04329494","title":"PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":49,"lead_sponsor_name":"City of Hope Medical Center","has_results":false},{"nct_id":"NCT04252560","title":"The Impact of Gut Microbiota in Anastomoses Insufficiency After Resection and Direct Anastomosis for Colorectal Cancer.","phase":"","overall_status":"COMPLETED","enrollment_count":45,"lead_sponsor_name":"Uppsala University Hospital","has_results":false},{"nct_id":"NCT04929015","title":"Peritoneal Carcinomatosis Leveraging ctDNA Guided Treatment in GI Cancer Study (PERICLES Study)","phase":"NA","overall_status":"UNKNOWN","enrollment_count":30,"lead_sponsor_name":"Rutgers, The State University of New Jersey","has_results":false},{"nct_id":"NCT07118176","title":"Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":30,"lead_sponsor_name":"Jonsson Comprehensive Cancer Center","has_results":false},{"nct_id":"NCT04898842","title":"Feasibility Study of a 4 Stage Bowel Obstruction Cancer Diet","phase":"NA","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"Royal Surrey County Hospital NHS Foundation Trust","has_results":false},{"nct_id":"NCT07411599","title":"Dual Administration Of Intraperitoneal And Intravenous TROP2-Directed CAR-NK With TGF-Beta Receptor 2 (TGFBR2) Knock Out (KO) Therapy For Colorectal Cancer-Related Peritoneal Carcinomatosis: A Phase 1/2 Trial (\"Chip-CRC Trial\")","phase":"PHASE1, PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":28,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":false},{"nct_id":"NCT04966715","title":"Inferior Epigastric Lymph Node in Colorectal Carcinosis","phase":"NA","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"Jules Bordet Institute","has_results":false},{"nct_id":"NCT03246321","title":"PIPAC for Peritoneal Metastases of Colorectal Cancer","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"Koen Rovers","has_results":false},{"nct_id":"NCT03161041","title":"Perioperative Chemotherapy With Bevacizumab for Colorectal Carcinomatosis French Part of the Main Bev-IP Study","phase":"PHASE2","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Hospices Civils de Lyon","has_results":false},{"nct_id":"NCT01095523","title":"Prospective Randomized Trial Evaluating Mandatory Second Look Surgery With HIPEC and CRS vs. Standard of Care in Subjects at High Risk of Developing Colorectal Peritoneal Metastases","phase":"PHASE2","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false}],"total":13},"guidelines":[],"source":"Drug Landscape verified database"}